Catheter Precision Inc. Common Stock (VTAK)

FairStock Score: 57/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach this as a Graham-style bargain hunt: what am I buying, and what is my margin of safety? Catheter Precision sells cardiac electrophysiology tools, including its View into Ventricular Onset System and LockeT. Those address real clinical needs, and FairStock lists revenue growth of 202.10%. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $1.0M versus $212,000 in fiscal Q2 2025, so there is commercial progress. But I am not buying sales alone. That same fiscal Q2 2026 period produced a net loss of $3.3M and diluted EPS of -$0.92. In fiscal Q1 2026, revenue was $432,000 and net loss was $1.7M. For fiscal 2025, revenue was $819,000 while net loss was $17.2M; in fiscal 2024, revenue was $420,000 and net loss was $16.6M. The company is losing many dollars for every dollar of revenue. FairStock's trailing free cash flow is -$9.6M, a FCF yield of -375.6% against a $2.6M market cap. It also shows D/E of 0.80, ROE of -111.35%, Altman Z-score -12.55, and Piotroski F-Score 3/9. At the 2026-10-13 close of $1.06, P/B is 0.22, and P/E is -0.26; a low P/B can tempt, but book value is not earning power. The Lynch category is none because it has lost money in each of the last four years. With 17 employees, no sustained profit, and heavy cash burn, it has no proven moat and likely depends on outside capital. This is speculative optionality, not a margin of safety.

In plain English: Catheter Precision makes heart-rhythm medical devices. The company is very small, has lost money for years, and spends more cash than it brings in, even though sales grew from a tiny base. At $1.06, the stock may look inexpensive compared with its accounting assets, but the weak losses mean it does not look like a healthy bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer